Overview

Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the safety of ridinilazole in adolescent subjects and how ridinilazole is metabolized.
Phase:
Phase 3
Details
Lead Sponsor:
Summit Therapeutics
Collaborator:
Department of Health and Human Services
Treatments:
Vancomycin